New in Town

KoamTac, 116 Village Boulevard, Suite 305, Princeton 08540; 609-734-4335. Home page:

KoamTac, a company that designs, develops, and sells barcode data collectors, has established offices in Forrestal Center. Some of the company’s products work along with Samsung Smartphones to enable transmission of inventory data from the field back to the office.

Crosstown Moves

Brogan Tennyson Group, 2245 Route 130, Suite 102, Dayton 08810-2420; 732-355-0700. William T. Quinn, president. Home page:

The Brogan Tennyson Group, which bills itself as a “luxury advertising” firm, has moved from Stults Road to Route 130. The agency, founded in 1992, also has an office in Atlanta.

Joseph Jingoli & Son, Construction, 100 Lenox Drive, Suite 100, Lawrenceville 08648; 609-896-3111; fax, 609-219-0799. Joseph Jingoli Jr., president. Home page:

Joseph Jingoli & Son, a commercial construction firm founded in 1921 has moved from 3131 Princeton Pike to its new headquarters on Lenox Drive.

The firm, which has regional offices in Las Vegas, Atlantic City, New York, Washington, D.C., and West Chester, Pennsylvania, is still a family-managed affair. Joseph Jingoli Jr. is the firm’s CEO, while Michael Jingoli is its CFO and COO. Jingoli’s largest projects include the Xanadu complex at the Meadowlands in East Rutherford, the South Amboy Waterfront Development Project, and the Philadelphia Convention Center.

National Medical Systems Inc. (Corporate Health Management), 1675 Whitehorse-Mercerville Road, Suite 205, Hamilton 08619; 609-588-6800; fax, 609-588-0234. William Palmieri, president.

National Medical Health Systems, which provides drug screenings and corporate employee physicals, has moved from Route 33 to Whitehorse-Mercerville Road, a slightly larger space for its nine employees.

Sypek & Sandford Agency Inc., 1569 Parkway, Buildings F&G, Ewing 08628; 609-896-7000; fax, 609-896-0691. Stephen J. Pers, president. Home page:

The Sypek and Sandford Agency has moved its offices from 3131 Princeton Pike to Ewing. The agency, founded in 1932, provides commercial, business, health, life, auto, and benefits coverage.


Joseph L. Stonaker, 41 Leigh Avenue, Princeton 08540.

Former Plainsboro Township attorney Joseph Stonaker, who operated his own law firm on Lehigh Avenue since 1995, has retired from private practice.

Stonaker served as Plainsboro’s attorney from 1974 until the end of 2007, and also maintained Stonaker & Stonaker on Leigh Avenue.

Board News

Agile Therapeutics Inc., 366 Wall Street, Princeton 08540; 609-683-1880. Thomas M. Rossi, president. Home page:

Agile Therapeutics has announced the appointment of Al Altomari, as chairman of its board of directors. Altomari, who also holds the position of CEO of Barrier Therapeutics, has been involved with the development and commercialization of specialty pharmaceutical products, in particular in women’s health and dermatology, for the past 25 years.

Agile has recently completed Phase 2b clinical development of a low dose contraceptive patch.

While he was with Johnson & Johnson, prior to joining Barrier Therapeutics, Altomari led the integration of Ortho Dermatological and Neutrogena Professional, two J & J divisions. He also served as vice president of Ortho-McNeil Pharmaceutical’s Women’s Health Care Franchise, where he introduced several life cycle and new product development initiatives, including the launch of Ortho EVRA, the only contraceptive patch on the market today.

Altomari serves on the advisory board of Le Bow College, Drexel’s Business School.

Clinical Trial Begins

Cornerstone Pharmaceutical, 1 Duncan Drive, Cranbury 08512; 609-409-7050; fax, 609-409-6035. Bob Rodriguez, president & COO. Home page:

The lead product from a new class of agents called Altered Energy Metabolism Directed (AEMD) compounds developed by Cornerstone Pharmaceuticals from technology licensed from the Research Foundation of the State University of New York, on behalf of Stony Brook University, has been approved by the U.S. Food and Drug Administration (FDA) for evaluation in Phase I/II clinical trials to treat cancer.

The technology resulted from research by SBU professors Paul M. Bingham and Zuzana Zachar An initial clinical trial will be sponsored by Cornerstone Pharmaceuticals, the exclusive licensee and developer of discoveries made by Bingham and Zachar.

Cornerstone Pharmaceuticals, which has facilities in Cranbury, will evaluate the drug family member designated CPI-613, the first of this novel class of agents, in cancer patients. The clinical trial is classified as FDA-approved safety and early efficacy trial.


Barbara Radzki, 40, on August 17. She was president of Hopewell Valley Vineyards, and was profiled in a U.S. 1 article on August 6. A memorial service will be held on Thursday, September 11, her birthday. The time of day and place for the memorial have not yet been determined.

Peter J. Jensen, 52, on July 13. He worked in finance at Merck, and was an elder at Nassau Presbyterian Church.

Facebook Comments